Minireview: Alternative activation pathways for the androgen receptor in prostate cancer.

Abstract excerpt

Advanced prostate tumors, which are androgen dependent, are often initially treated in the clinic with hormone ablation therapy, either through surgical castration or administration of small-molecule antiandrogens. Most tumors respond favorably to these treatments, exhibiting regression of the tumor, amelioration of symptoms, and a decrease of prostate-specific antigen in patient sera. However, with time, the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cytokines
• Share to Gene Expression Regulation, Neoplastic
• Share to Intercellular Signaling Peptides and Proteins